Glenmark Pharmaceuticals
NSEI:GLENMARK Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
WA
Consensus Narrative from 13 Analysts
Lirafit Launch And BeiGene Partnership Set To Accelerate Revenue Growth And Market Share
Key Takeaways Upcoming biosimilar launches and strategic oncology partnerships could significantly boost Glenmark's revenue and market share in India. Glenmark's global expansion and new product launches may enhance revenue growth, while resolving GMP issues could improve margins and reduce operational costs.
View narrative₹1.74k
FV
19.6% undervalued intrinsic discount11.04%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
about 1 month ago author updated this narrative